These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653 [TBL] [Abstract][Full Text] [Related]
25. Dimethyl sulfoxide inhibits metabolic activation of sulindac. Swanson BN; Mojaverian P; Boppana VK; Vlasses PH; Ferguson RK Ann N Y Acad Sci; 1983; 411():381-2. PubMed ID: 6576719 [No Abstract] [Full Text] [Related]
26. Metabolic disposition of 5-iminodaunorubicin in the rat. Peters JH; Gordon GR; Kashiwase D; Acton EM Cancer Res; 1984 Apr; 44(4):1453-9. PubMed ID: 6704961 [TBL] [Abstract][Full Text] [Related]
27. The disposition of [3H]diisopropylfluorophosphate in guinea pigs after inhalation. Scimeca JA; Martin BR Drug Metab Dispos; 1988; 16(4):534-9. PubMed ID: 2903019 [TBL] [Abstract][Full Text] [Related]
28. Metabolism of the polynuclear sulfur heterocycle benzo[b]phenanthro[2,3-d]thiophene by rodent liver microsomes: evidence for multiple pathways in the bioactivation of benzo[b]phenanthro[2,3-d]thiophene. Yuan ZX; Sikka HC; Munir S; Kumar A; Muruganandam AV; Kumar S Chem Res Toxicol; 2003 Dec; 16(12):1581-8. PubMed ID: 14680372 [TBL] [Abstract][Full Text] [Related]
29. The disposition of sulindac. Duggan DE; Hare LE; Ditzler CA; Lei BW; Kwan KC Clin Pharmacol Ther; 1977 Mar; 21(3):326-35. PubMed ID: 300048 [TBL] [Abstract][Full Text] [Related]
30. Ibuprofen and sulindac kinetics in alcoholic liver disease. Juhl RP; Van Thiel DH; Dittert LW; Albert KS; Smith RB Clin Pharmacol Ther; 1983 Jul; 34(1):104-9. PubMed ID: 6861431 [TBL] [Abstract][Full Text] [Related]
31. Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa. Graham DY; Smith JL; Holmes GI; Davies RO Clin Pharmacol Ther; 1985 Jul; 38(1):65-70. PubMed ID: 3874038 [TBL] [Abstract][Full Text] [Related]
32. Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac. Sitar DS; Owen JA; MacDougall B; Hunter T; Mitenko PA Clin Pharmacol Ther; 1985 Aug; 38(2):228-34. PubMed ID: 4017423 [TBL] [Abstract][Full Text] [Related]
33. Influence of cholestyramine resin administration on single dose sulindac pharmacokinetics. Malloy MJ; Ravis WR; Pennell AT; Hagan DR; Betagari S; Doshi DH Int J Clin Pharmacol Ther; 1994 Jun; 32(6):286-9. PubMed ID: 7921528 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 2nd communication: distribution to organs and tissues in male, female and pregnant rats, and characteristics of protein binding in plasma. Steinke W; Ahr HJ; Hirayama M Arzneimittelforschung; 1997 Aug; 47(8):939-48. PubMed ID: 9296280 [TBL] [Abstract][Full Text] [Related]
35. Relationship between parathion and paraoxon toxicokinetics, lung metabolic activity, and cholinesterase inhibition in guinea pig and rabbit lungs. Lessire F; Gustin P; Delaunois A; Bloden S; Nemmar A; Vargas M; Ansay M Toxicol Appl Pharmacol; 1996 Jun; 138(2):201-10. PubMed ID: 8658521 [TBL] [Abstract][Full Text] [Related]
36. Sulindac disposition when given once and twice daily. Swanson BN; Boppana VK; Vlasses PH; Holmes GI; Monsell K; Ferguson RK Clin Pharmacol Ther; 1982 Sep; 32(3):397-403. PubMed ID: 7049504 [TBL] [Abstract][Full Text] [Related]
37. Sulindac metabolism: the importance of an intact colon. Strong HA; Warner NJ; Renwick AG; George CF Clin Pharmacol Ther; 1985 Oct; 38(4):387-93. PubMed ID: 4042521 [TBL] [Abstract][Full Text] [Related]
38. Placental transfer of sulindac and its active sulfide metabolite in humans. Kramer WB; Saade G; Ou CN; Rognerud C; Dorman K; Mayes M; Moise KJ Am J Obstet Gynecol; 1995 Mar; 172(3):886-90. PubMed ID: 7892880 [TBL] [Abstract][Full Text] [Related]
39. Sulfoxidation of mercapturic acids derived from tri- and tetrachloroethene by cytochromes P450 3A: a bioactivation reaction in addition to deacetylation and cysteine conjugate beta-lyase mediated cleavage. Werner M; Birner G; Dekant W Chem Res Toxicol; 1996; 9(1):41-9. PubMed ID: 8924615 [TBL] [Abstract][Full Text] [Related]
40. Tissue distribution of prednisolone in the rabbit. Khalafallah N; Jusko WJ J Pharmacol Exp Ther; 1984 Jun; 229(3):719-25. PubMed ID: 6726655 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]